p75NTR as a therapeutic target for neuropsychiatric diseases

Current Molecular Pharmacology

Volumn 2, Issue 1, 2009, Pages 70-76

  Fujii, Takashi ^a   Kunugi, Hiroshi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Alzheimer's disease; Depression; Drug discovery; Knockout (KO) mouse; Neurotrophin; p75NTR; Proneurotrophin; Schizophrenia

Indexed keywords

CAFFEINE DERIVATIVE; LM11A 24; NEUROTROPHIN RECEPTOR P75; UNCLASSIFIED DRUG; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BINDING AFFINITY; CELL CULTURE; CELL DEATH; CELL SURVIVAL; COGNITION; DEPRESSION; DRUG TARGETING; GENOME; HUMAN; KNOCKOUT GENE; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; RNA SPLICING; SCHIZOPHRENIA; UPREGULATION; ANIMAL; DEGENERATIVE DISEASE; DRUG ANTAGONISM; DRUG DEVELOPMENT; GENETICS; MENTAL DISEASE; METABOLISM; MOUSE; MOUSE MUTANT; REVIEW;

ANIMALS; DRUG DISCOVERY; MENTAL DISORDERS; MICE; MICE, KNOCKOUT; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; RECEPTOR, NERVE GROWTH FACTOR;

EID: 77449115618     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467210902010070     Document Type: Article

References (124)

1. Chao, M. V.; Bothwell, M. A.; Ross, A. H.; Koprowski, H.; Lanahan, A. A.; Buck, C. R.; Sehgal, A. Gene transfer and molecular cloning of the human NGF receptor. Science 1986, 232, 518-521.
2. Grob, P. M.; Ross, A. H.; Koprowski, H.; Bothwell, M. Characterization of the human melanoma nerve growth factor receptor. J. Biol. Chem. 1985, 260, 8044-8049.
3. Herrup, K.; Shooter, E. M. Properties of the beta nerve growth factor receptor of avian dorsal root ganglia. Proc. Natl. Acad. Sci. USA 1973, 70, 3884-3888.
4. Johnson, D.; Lanahan, A.; Buck, C. R.; Sehgal, A.; Morgan, C.; Mercer, E.; Bothwell, M.; Chao, M. Expression and structure of the human NGF receptor. Cell 1986, 47, 545-554.
5. Radeke, M. J.; Misko, T. P.; Hsu, C.; Herzenberg, L. A.; Shooter, E. M. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 1987, 325, 593-597.
6. Reichardt, L. F. Neurotrophin-regulated signalling pathways. Philos. Trans. R Soc. Lond. B Biol. Sci. 2006, 361, 1545-1564.
7. Sohrabji, F.; Lewis, D. K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front. Neuroendocrinol. 2006, 27, 404-414.
8. Hubka, P. Neural network plasticity, BDNF and behavioral interventions in Alzheimer's disease. Bratisl. Lek. Listy 2006, 107, 395-401.
9. Schulte-Herbruggen, O.; Braun, A.; Rochlitzer, S.; Jockers-Scherubl, M. C.; Hellweg, R. Neurotrophic factors-a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases? Curr. Med. Chem. 2007, 14, 2318-2329.
10. Martinowich, K.; Manji, H.; Lu, B. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 2007, 10, 1089-1093.
11. Post, R. M. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J. Psychiatr. Res. 2007, 41, 979-990.
12. Durany, N.; Thome, J. Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur. Psychiatry 2004, 19, 326-337.
13. Buckley, P. F.; Mahadik, S.; Pillai, A.; Terry, A., Jr. Neurotrophins and schizophrenia. Schizophr. Res. 2007, 94, 1-11.
14. Welcher, A. A.; Bitler, C. M.; Radeke, M. J.; Shooter, E. M. Nerve growth factor binding domain of the nerve growth factor receptor. Proc. Natl. Acad. Sci. USA 1991, 88, 159-163.
15. He, X. L.; Garcia, K. C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004, 304, 870-875.
16. Chapman, B. S.; Eckart, M. R.; Kaufman, S. E.; Lapointe, G. R. O-linked oligosaccharide on the 75-kDa neurotrophin receptor. J. Neurochem. 1996, 66, 1707-1716.
17. Coulson, E. J.; Reid, K.; Baca, M.; Shipham, K. A.; Hulett, S. M.; Kilpatrick, T. J.; Bartlett, P. F. Chopper, a new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J. Biol. Chem. 2000, 275, 30537-30545.
18. Liepinsh, E.; Ilag, L. L.; Otting, G.; Ibanez, C. F. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J. 1997, 16, 4999-5005.
19. Coulson, E. J.; Reid, K.; Shipham, K. M.; Morley, S.; Kilpatrick, T. J.; Bartlett, P. F. The role of neurotransmission and the Chopper domain in p75 neurotrophin receptor death signaling. Prog. Brain Res. 2004, 146, 41-62.
20. Dobrowsky, R. T.; Werner, M. H.; Castellino, A. M.; Chao, M. V.; Hannun, Y. A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994, 265, 1596-1599.
21. Carter, B. D.; Kaltschmidt, C.; Kaltschmidt, B.; Offenhauser, N.; BohmMatthaei, R.; Baeuerle, P. A.; Barde, Y. A. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 1996, 272, 542-545.
22. Roux, P. P.; Bhakar, A. L.; Kennedy, T. E.; Barker, P. A. The p75 neurotrophin receptor activates Akt (protein kinase B) through a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 2001, 276, 23097-23104.
23. Friedman, W. J. Neurotrophins induce death of hippocampal neurons via the p75 receptor. J. Neurosci. 2000, 20, 6340-6346.
24. Barker, P. A. p75NTR is positively promiscuous: novel partners and new insights. Neuron 2004, 42, 529-533.
25. Hempstead, B. L.; Martin-Zanca, D.; Kaplan, D. R.; Parada, L. F.; Chao, M. V. High-affinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor. Nature 1991, 350, 678-683.
26. Battleman, D. S.; Geller, A. I.; Chao, M. V. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines highaffinity NGF binding. J. Neurosci. 1993, 13, 941-951.
27. Benedetti, M.; Levi, A.; Chao, M. V. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc. Natl. Acad. Sci. USA 1993, 90, 7859-7863.
28. Mahadeo, D.; Kaplan, L.; Chao, M. V.; Hempstead, B. L. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J. Biol. Chem. 1994, 269, 6884-6891.
29. Hantzopoulos, P. A.; Suri, C.; Glass, D. J.; Goldfarb, M. P.; Yancopoulos, G. D. The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron 1994, 13, 187-201.
30. Canossa, M.; Twiss, J. L.; Verity, A. N.; Shooter, E. M. p75(NGFR) and TrkA receptors collaborate to rapidly activate a p75(NGFR)-associated protein kinase. EMBO J. 1996, 15, 3369-3376.
31. Nykjaer, A.; Lee, R.; Teng, K. K.; Jansen, P.; Madsen, P.; Nielsen, M. S.; Jacobsen, C.; Kliemannel, M.; Schwarz, E.; Willnow, T. E.; Hempstead, B. L.; Petersen, C. M. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004, 427, 843-848.
32. Teng, H. K.; Teng, K. K.; Lee, R.; Wright, S.; Tevar, S.; Almeida, R. D.; Kermani, P.; Torkin, R.; Chen, Z. Y.; Lee, F. S.; Kraemer, R. T.; Nykjaer, A.; Hempstead, B. L. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 2005, 25, 5455-5463.
33. Yaar, M.; Zhai, S.; Pilch, P. F.; Doyle, S. M.; Eisenhauer, P. B.; Fine, R. E.; Gilchrest, B. A. Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease. J. Clin. Invest. 1997, 100, 2333-2340.
34. Della-Bianca, V.; Rossi, F.; Armato, U.; Dal-Pra, I.; Costantini, C.; Perini, G.; Politi, V.; Della Valle, G. Neurotrophin p75 receptor is involved in neuronal damage by prion peptide-(106-126). J. Biol. Chem. 2001, 276, 38929-38933.
35. Tuffereau, C.; Benejean, J.; Blondel, D.; Kieffer, B.; Flamand, A. Lowaffinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 1998, 17, 7250-729.
36. Tuffereau, C.; Schmidt, K.; Langevin, C.; Lafay, F.; Dechant, G.; Koltzenburg, M. The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J. Virol. 2007, 81, 13622-30.
37. Wang, K. C.; Kim, J. A.; Sivasankaran, R.; Segal, R.; He, Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002, 420, 74-78.
38. Mi, S.; Lee, X.; Shao, Z.; Thill, G.; Ji, B.; Relton, J.; Levesque, M.; Allaire, N.; Perrin, S.; Sands, B.; Crowell, T.; Cate, R. L.; McCoy, J. M.; Pepinsky, R. B. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 2004, 7, 221-228.
39. Blochl, A.; Blochl, R. A cell-biological model of p75NTR signaling. J. Neurochem. 2007, 102, 289-305.
40. von Schack, D.; Casademunt, E.; Schweigreiter, R.; Meyer, M.; Bibel, M.; Dechant, G. Complete ablation of the neurotrophin receptor p75NTR causes defects both in the nervous and the vascular system. Nat. Neurosci. 2001, 4, 977-978.
41. Lee, K. F.; Li, E.; Huber, L. J.; Landis, S. C.; Sharpe, A. H.; Chao, M. V.; Jaenisch, R. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 1992, 69, 737-749.
42. Chapman, B. S. A region of the 75 kDa neurotrophin receptor homologous to the death domains of TNFR-I and Fas. FEBS Lett. 1995, 374, 216-220.
43. Baldwin, A. N.; Shooter, E. M. Zone mapping of the binding domain of the rat low affinity nerve growth factor receptor by the introduction of novel Nglycosylation sites. J. Biol. Chem. 1995, 270, 4594-4602.
44. Langevin, C.; Jaaro, H.; Bressanelli, S.; Fainzilber, M.; Tuffereau, C. Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J. Biol. Chem. 2002, 277, 37655-37662.
45. Kanning, K. C.; Hudson, M.; Amieux, P. S.; Wiley, J. C.; Bothwell, M.; Schecterson, L. C. Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J. Neurosci. 2003, 23, 5425-5436.
46. Frankowski, H.; Castro-Obregon, S.; del Rio, G.; Rao, R. V.; Bredesen, D. E. PLAIDD, a type II death domain protein that interacts with p75 neurotrophin receptor. Neuromolecular Med. 2002, 1, 153-170.
47. Wang, X.; Shao, Z.; Zetoune, F. S.; Zeidler, M. G.; Gowrishankar, K.; Vincenz, C. NRADD, a novel membrane protein with a death domain involved in mediating apoptosis in response to ER stress. Cell Death Differ. 2003, 10, 580-591.
48. Murray, E.; Malley, S. E.; Qiao, L. Y.; Hu, V. Y.; Vizzard, M. A. Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder. J. Urol. 2004, 172, 2434-2439.
49. Davies, A. M.; Lee, K. F.; Jaenisch, R. p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron 1993, 11, 565-574.
50. Lee, K. F.; Davies, A. M.; Jaenisch, R. p75-deficient embryonic dorsal root sensory and neonatal sympathetic neurons display a decreased sensitivity to NGF. Development 1994, 120, 1027-1033.
51. Bentley, C. A.; Lee, K. F. p75 is important for axon growth and schwann cell migration during development. J. Neurosci. 2000, 20, 7706-7715.
52. Greferath, U.; Bennie, A.; Kourakis, A.; Bartlett, P. F.; Murphy, M.; Barrett, G. L. Enlarged cholinergic forebrain neurons and improved spatial learning in p75 knockout mice. Eur. J. Neurosci. 2000, 12, 885-893.
53. Yeo, T. T.; Chua-Couzens, J.; Butcher, L. L.; Bredesen, D. E.; Cooper, J. D.; Valletta, J. S.; Mobley, W. C.; Longo, F. M. Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J. Neurosci. 1997, 17, 7594-7605.
54. Naumann, T.; Casademunt, E.; Hollerbach, E.; Hofmann, J.; Dechant, G.; Frotscher, M.; Barde, Y. A. Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J. Neurosci. 2002, 22, 2409-2418.
55. Bamji, S. X.; Majdan, M.; Pozniak, C. D.; Belliveau, D. J.; Aloyz, R.; Kohn, J.; Causing, C. G.; Miller, F. D. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 1998, 140, 911-923.
56. Frade, J. M.; Barde, Y. A. Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 1999, 126, 683-690.
57. Ferri, C. C.; Moore, F. A.; Bisby, M. A. Effects of facial nerve injury on mouse motoneurons lacking the p75 low-affinity neurotrophin receptor. J. Neurobiol. 1998, 34, 1-9.
58. Troy, C. M.; Friedman, J. E.; Friedman, W. J. Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. J. Biol. Chem. 2002, 277, 34295-34302.
59. Zagrebelsky, M.; Holz, A.; Dechant, G.; Barde, Y. A.; Bonhoeffer, T.; Korte, M. The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J. Neurosci. 2005, 25, 9989-9999.
60. Rosch, H.; Schweigreiter, R.; Bonhoeffer, T.; Barde, Y. A.; Korte, M. The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc. Natl. Acad. Sci. USA 2005, 102, 7362-7367.
61. Woo, N. H.; Teng, H. K.; Siao, C. J.; Chiaruttini, C.; Pang, P. T.; Milner, T. A.; Hempstead, B. L.; Lu, B. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat. Neurosci. 2005, 8, 1069-1077.
62. Sato, T.; Doi, K.; Taniguchi, M.; Yamashita, T.; Kubo, T.; Tohyama, M. Progressive hearing loss in mice carrying a mutation in the p75 gene. Brain Res. 2006, 1091, 224-234.
63. Young, K. M.; Merson, T. D.; Sotthibundhu, A.; Coulson, E. J.; Bartlett, P. F. p75 neurotrophin receptor expression defines a population of BDNFresponsive neurogenic precursor cells. J. Neurosci. 2007, 27, 5146-5155.
64. Peterson, D. A.; Dickinson-Anson, H. A.; Leppert, J. T.; Lee, K. F.; Gage, F. H. Central neuronal loss and behavioral impairment in mice lacking neurotrophin receptor p75. J. Comp. Neurol. 1999, 404, 1-20.
65. Brennan, C.; Rivas-Plata, K.; Landis, S. C. The p75 neurotrophin receptor influences NT-3 responsiveness of sympathetic neurons in vivo. Nat. Neurosci. 1999, 2, 699-705.
66. Wright, J. W.; Alt, J. A.; Turner, G. D.; Krueger, J. M. Differences in spatial learning comparing transgenic p75 knockout, New Zealand Black, C57BL/6, and Swiss Webster mice. Behav. Brain Res. 2004, 153, 453-458.
67. Peterson, D. A.; Leppert, J. T.; Lee, K. F.; Gage, F. H. Basal forebrain neuronal loss in mice lacking neurotrophin receptor p75. Science 1997, 277, 837-839.
68. Volosin, M.; Song, W.; Almeida, R. D.; Kaplan, D. R.; Hempstead, B. L.; Friedman, W. J. Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J. Neurosci. 2006, 26, 7756-7766.
69. Coulson, E. J.; Reid, K.; Murray, S. S.; Cheema, S. S.; Bartlett, P. F. Role of neurotrophin receptor p75NTR in mediating neuronal cell death following injury. Clin. Exp. Pharmacol. Physiol. 2000, 27, 537-541.
70. Curtis, R.; Adryan, K. M.; Stark, J. L.; Park, J. S.; Compton, D. L.; Weskamp, G.; Huber, L. J.; Chao, M. V.; Jaenisch, R.; Lee, K. F.; Lindsay, R.M.; Distefano, P.S. Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins. Neuron 1995, 14, 1201-1211.
71. Yamashita, T.; Tucker, K. L.; Barde, Y. A. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 1999, 24, 585-593.
72. Bergmann, I.; Priestley, J. V.; McMahon, S. B.; Brocker, E. B.; Toyka, K. V.; Koltzenburg, M. Analysis of cutaneous sensory neurons in transgenic mice lacking the low affinity neurotrophin receptor p75. Eur. J. Neurosci. 1997, 9, 18-28.
73. Scott, A. L.; Borisoff, J. F.; Ramer, M. S. Deafferentation and neurotrophinmediated intraspinal sprouting: a central role for the p75 neurotrophin receptor. Eur. J. Neurosci. 2005, 21, 81-92.
74. Jansen, P.; Giehl, K.; Nyengaard, J. R.; Teng, K.; Lioubinski, O.; Sjoegaard, S. S.; Breiderhoff, T.; Gotthardt, M.; Lin, F.; Eilers, A.; Petersen, C. M.; Lewin, G. R.; Hempstead, B. L.; Willnow, T. E.; Nykjaer, A. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat. Neurosci. 2007, 10, 1449-1457.
75. Bartus, R. T.; Dean, R. L., 3rd; Beer, B.; Lippa, A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217, 408-414.
76. Coyle, J. T.; Price, D. L.; DeLong, M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983, 219, 1184-1190.
77. Perry, E.; Walker, M.; Grace, J.; Perry, R. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 1999, 22, 273-280.
78. Van der Zee, C. E.; Ross, G. M.; Riopelle, R. J.; Hagg, T. Survival of cholinergic forebrain neurons in developing p75NGFR-deficient mice. Science 1996, 274, 1729-1732.
79. Selkoe, D. J. Alzheimer's disease is a synaptic failure. Science 2002, 298, 789-791.
80. Yuan, J.; Yankner, B. A. Apoptosis in the nervous system. Nature 2000, 407, 802-809.
81. Caughey, B.; Lansbury, P. T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 2003, 26, 267-298.
82. Fahnestock, M.; Michalski, B.; Xu, B.; Coughlin, M. D. The precursor pronerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol. Cell Neurosci. 2001, 18, 210-220.
83. Peng, S.; Wuu, J.; Mufson, E. J.; Fahnestock, M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J. Neuropathol. Exp. Neurol. 2004, 63, 641-649.
84. Counts, S. E.; Mufson, E. J. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J. Neuropathol. Exp. Neurol. 2005, 64, 263-272.
85. Pedraza, C. E.; Podlesniy, P.; Vidal, N.; Arevalo, J. C.; Lee, R.; Hempstead, B.; Ferrer, I.; Iglesias, M.; Espinet, C. Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. Am. J. Pathol. 2005, 166, 533-543.
86. Cuello, A. C.; Bruno, M. A. The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer's disease. Neurochem. Res. 2007, 32, 1041-1045.
87. Kuner, P.; Schubenel, R.; Hertel, C. Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells. J. Neurosci. Res. 1998, 54, 798-804.
88. Sotthibundhu, A.; Sykes, A. M.; Fox, B.; Underwood, C. K.; Thangnipon, W.; Coulson, E. J. Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J. Neurosci. 2008, 28, 3941-3946.
89. Yaar, M.; Zhai, S.; Fine, R. E.; Eisenhauer, P. B.; Arble, B. L.; Stewart, K. B.; Gilchrest, B. A. Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J. Biol. Chem. 2002, 277, 7720-7725.
90. Hashimoto, Y.; Kaneko, Y.; Tsukamoto, E.; Frankowski, H.; Kouyama, K.; Kita, Y.; Niikura, T.; Aiso, S.; Bredesen, D. E.; Matsuoka, M.; Nishimoto, I. Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR/PLAIDD. J. Neurochem. 2004, 90, 549-558.
91. Costantini, C.; Della-Bianca, V.; Formaggio, E.; Chiamulera, C.; Montresor, A.; Rossi, F. The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of beta-amyloid. Exp. Cell Res. 2005, 311, 126-134.
92. Tsukamoto, E.; Hashimoto, Y.; Kanekura, K.; Niikura, T.; Aiso, S.; Nishimoto, I. Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells. J. Neurosci. Res. 2003, 73, 627-636.
93. Zhang, Y.; Hong, Y.; Bounhar, Y.; Blacker, M.; Roucou, X.; Tounekti, O.; Vereker, E.; Bowers, W. J.; Federoff, H. J.; Goodyer, C. G.; LeBlanc, A. p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity. J. Neurosci. 2003, 23, 7385-7394.
94. Susen, K.; Blochl, A. Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75. J. Mol. Med. 2005, 83, 720-735.
95. Perini, G.; Della-Bianca, V.; Politi, V.; Della Valle, G.; Dal-Pra, I.; Rossi, F.; Armato, U. Role of p75 neurotrophin receptor in the neurotoxicity by betaamyloid peptides and synergistic effect of inflammatory cytokines. J. Exp. Med. 2002, 195, 907-918.
96. Binder, D. K. The role of BDNF in epilepsy and other diseases of the mature nervous system. Adv. Exp. Med. Biol. 2004, 548, 34-56.
97. Kunugi, H.; Hashimoto, R.; Yoshida, M.; Tatsumi, M.; Kamijima, K. A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 129, 44-46.
98. McGregor, S.; Strauss, J.; Bulgin, N.; De Luca, V.; George, C. J.; Kovacs, M.; Kennedy, J. L. p75(NTR) gene and suicide attempts in young adults with a history of childhood-onset mood disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144, 696-700.
99. Marenco, S.; Weinberger, D. R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev. Psychopathol. 2000, 12, 501-527.
100. Weinberger, D. R. From neuropathology to neurodevelopment. Lancet 1995, 346, 552-557.
101. Pilowsky, L. S.; Kerwin, R. W.; Murray, R. M. Schizophrenia: a neurodevelopmental perspective. Neuropsychopharmacology 1993, 9, 83-91.
102. Seeman, P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987, 1, 133-152.
103. Laruelle, M.; Abi-Dargham, A.; van Dyck, C. H.; Gil, R.; D'Souza, C. D.; Erdos, J.; McCance, E.; Rosenblatt, W.; Fingado, C.; Zoghbi, S. S.; Baldwin, R. M.; Seibyl, J. P.; Krystal, J. H.; Charney, D. S.; Innis, R. B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. USA 1996, 93, 9235-9240.
104. Braff, D.; Stone, C.; Callaway, E.; Geyer, M.; Glick, I.; Bali, L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15, 339-343.
105. Braff, D. L.; Grillon, C.; Geyer, M. A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 1992, 49, 206-215.
106. Parwani, A.; Duncan, E. J.; Bartlett, E.; Madonick, S. H.; Efferen, T. R.; Rajan, R.; Sanfilipo, M.; Chappell, P. B.; Chakravorty, S.; Gonzenbach, S.; Ko, G. N.; Rotrosen, J. P. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol. Psychiatry 2000, 47, 662-669.
107. Kunugi, H.; Tanaka, M.; Hori, H.; Hashimoto, R.; Saitoh, O.; Hironaka, N. Prepulse inhibition of acoustic startle in Japanese patients with chronic schizophrenia. Neurosci. Res. 2007, 59, 23-28.
108. Davies, A. M. Nerve growth factor synthesis and nerve growth factor receptor expression in neural development. Int. Rev. Cytol. 1991, 128, 109-138.
109. Rajakumar, N.; Leung, L. S.; Ma, J.; Rajakumar, B.; Rushlow, W. Altered neurotrophin receptor function in the developing prefrontal cortex leads to adult-onset dopaminergic hyperresponsivity and impaired prepulse inhibition of acoustic startle. Biol. Psychiatry 2004, 55, 797-803.
110. McGrath, J. J.; Feron, F. P.; Burne, T. H.; Mackay-Sim, A.; Eyles, D. W. Vitamin D3-implications for brain development. J. Steroid Biochem. Mol. Biol. 2004, 89-90, 557-560.
111. Gao, X.; Daugherty, R. L.; Tourtellotte, W. G. Regulation of low affinity neurotrophin receptor (p75(NTR)) by early growth response (Egr) transcriptional regulators. Mol. Cell Neurosci. 2007, 36, 501-14.
112. Yamada, K.; Gerber, D. J.; Iwayama, Y.; Ohnishi, T.; Ohba, H.; Toyota, T.; Aruga, J.; Minabe, Y.; Tonegawa, S.; Yoshikawa, T. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc. Natl. Acad. Sci. USA 2007, 104, 2815-2820.
113. Geuze, E.; Vermetten, E.; Bremner, J. D. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol. Psychiatry 2005, 10, 160-184.
114. Honea, R.; Crow, T. J.; Passingham, D.; Mackay, C. E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 2005, 162, 2233-2245.
115. Steen, R. G.; Mull, C.; McClure, R.; Hamer, R. M.; Lieberman, J. A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 2006, 188, 510-518.
116. Campbell, S.; Macqueen, G. The role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci. 2004, 29, 417-426.
117. Czeh, B.; Lucassen, P. J. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257, 250-260.
118. Hof, P. R.; Haroutunian, V.; Friedrich, V. L., Jr.; Byne, W.; Buitron, C.; Perl, D. P.; Davis, K. L. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol. Psychiatry 2003, 53, 1075-1085.
119. Uranova, N. A.; Vostrikov, V. M.; Orlovskaya, D. D.; Rachmanova, V. I. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 2004, 67, 269-275.
120. Longo, F. M.; Vu, T. K.; Mobley, W. C. The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides. Cell Regul. 1990, 1, 189-195.
121. Longo, F. M.; Manthorpe, M.; Xie, Y. M.; Varon, S. Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J. Neurosci. Res. 1997, 48, 1-17.
122. Turner, B. J.; Murray, S. S.; Piccenna, L. G.; Lopes, E. C.; Kilpatrick, T. J.; Cheema, S. S. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice. J. Neurosci. Res. 2004, 78, 193-199.
123. Massa, S. M.; Xie, Y.; Yang, T.; Harrington, A. W.; Kim, M. L.; Yoon, S. O.; Kraemer, R.; Moore, L. A.; Hempstead, B. L.; Longo, F. M. Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGFinduced death. J. Neurosci. 2006, 26, 5288-5300.
124. Pehar, M.; Cassina, P.; Vargas, M. R.; Xie, Y.; Beckman, J. S.; Massa, S. M.; Longo, F. M.; Barbeito, L. Modulation of p75-dependent motor neuron death by a small non-peptidyl mimetic of the neurotrophin loop 1 domain. Eur. J. Neurosci. 2006, 24, 1575-1580.